Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by

The current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorouracil, leucovorin, and oxaliplatin. Although effective, the use of oxaliplatin can lead to known adverse events, mainly neurotoxicity that may be chronic.

Leave A Comment

Your email address will not be published. Required fields are marked *